| Literature DB >> 35335151 |
José M S Ponte1, Ana M L Seca1,2,3, Maria Carmo Barreto1,2.
Abstract
Although the genus Asparagopsis includes only two taxonomically accepted species, the published literature is unanimous about the invasive nature of this genus in different regions of the globe, and about the availability of large amounts of biomass for which it is important to find a commercial application. This review shows that extracts from Asparagospsis species have already been evaluated for antioxidant, antibacterial, antifungal, antiviral, antifouling, cytotoxic, antimethanogenic and enzyme-inhibitory activity. However, the tables presented herein show, with few exceptions, that the activity level displayed is generally low when compared with positive controls. Studies involving pure compounds being identified in Asparagopsis species are rare. The chemical compositions of most of the evaluated extracts are unknown. At best, the families of the compounds present are suggested. This review also shows that the volatile halogenated compounds, fatty acids and sterols that are biosynthesized by the Asparagopsis species are relatively well known. Many other non-volatile metabolites (halogen compounds, flavonoids, other phenolic compounds) seem to be produced by these species, but their chemical structures and properties haven'been investigated. This shows how much remains to be investigated regarding the secondary-metabolite composition of these species, suggesting further studies following more targeted methodologies.Entities:
Keywords: Asparagopsis; Asparagopsis armata; Asparagopsis taxiformis; antimicrobial; biological activities; halogenated compounds; secondary metabolites; sterols
Mesh:
Substances:
Year: 2022 PMID: 35335151 PMCID: PMC8948725 DOI: 10.3390/molecules27061787
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Antioxidant activity of Asparagopsis extracts.
| Species | Experimental Assay | Extract | Result | Units | Ref. |
|---|---|---|---|---|---|
|
| DPPH | Dichloromethane-mehtanol 1:1 | 6.25 | EC50 mg/mL | [ |
| BHA (positive control) | 0.04 | EC50 mg/mL | [ | ||
| BHT (positive control) | 0.06 | EC50 mg/mL | [ | ||
| Ascorbic acid (positive control) | 0.06 | EC50 mg/mL | [ | ||
| α-tocopherol (positive control) | 0.014 | EC50 mg/mL | [ | ||
| Methanol | 0.86 | EC50 mg/mL | [ | ||
| BHA (positive control) | 0.008 | EC50 mg/mL | [ | ||
| BHT (positive control) | 0.011 | EC50 mg/mL | [ | ||
| Methanol | 23.9 ± 0.3 | % radical-scavenging activity at 10 mg/mL | [ | ||
| Nitric oxide | Ethanol | 14.33 | EC25 mg dry algae/mL | [ | |
| Deoxyribose test | Water | 68.76 | % inhibition at 1 mg/mL | [ | |
|
| Hydrogen-peroxide scavenging | Chloroform | 11.07 ± 0.151 | % inhibition at 500 µg/mL | [ |
| Petroleum ether | 10.88 ± 0.139 | % inhibition at 500 µg/mL | [ | ||
| Methanol | 10.77 ± 0.131 | % inhibition at 500 µg/mL | [ | ||
| Ethyl acetate | 10.25 ± 0.136 | % inhibition at 500 µg/mL | [ | ||
| Ascorbic acid (positive control) | 17.59 ± 0.222 | % inhibition at 500 µg/mL | [ | ||
| Superoxide-radical scavenging | Methanol | 85.00 ± 0.002 | % scavenging activity at 500 µg/mL | [ | |
| Chloroform | 79.21 ± 0.006 | % scavenging activity at 500 µg/mL | [ | ||
| Petroleum ether | 47.00 ± 0.018 | % scavenging activity at 500 µg/mL | [ | ||
| Ethyl acetate | 45.00 ± 0.008 | % scavenging activity at 500 µg/mL | [ | ||
| Ascorbic acid (positive control) | 87.11 ± 0.0005 | % scavenging activity at 500 µg/mL | [ | ||
| FRAP (ferric-reducing antioxidant power) | Chloroform | 67.19 ± 0.0005 | % antioxidant activity at 500 µg/mL | [ | |
| Methanol | 65.63 ± 0.001 | % antioxidant activity at 500 µg/mL | [ | ||
| Petroleum ether | 64.06 ± 0.0005 | % antioxidant activity at 500 µg/mL | [ | ||
| Ethyl acetate | 54.69 ± 0.0005 | % antioxidant activity at 500 µg/mL | [ | ||
| Ascorbic acid (positive control) | 73.44 ± 0.002 | % antioxidant activity at 500 µg/mL | [ | ||
| Reducing activity | Water (M1) | 233.15 ± 5.15 | mg AAE/100 g dw a | [ | |
| Water (M2) | 174.38 ± 11.65 | mg AAE/100 g dw | [ | ||
| Ethanol (M1) | 1908.44 ± 59.15 | mg AAE/100 g dw | [ | ||
| Ethanol (M2) | 1156.86 ± 13.87 | mg AAE/100 g dw | [ | ||
| Methanol (M1) | 584.46 ± 15.36 | mg AAE/100 g dw | [ | ||
| Methanol (M2) | 1161.47 ± 14.43 | mg AAE/100 g dw | [ | ||
| Ethyl acetate (M1) | 409.60 ± 10.84 | mg AAE/100 g dw | [ | ||
| Ethyl acetate (M2) | 707.42 ± 98.78 | mg AAE/100 g dw | [ | ||
| DPPH | Water (M1) | 4.65 ± 0.29 | IC50 mg/mL | [ | |
| Water (M2) | 1.37 ± 0.03 | IC50 mg/mL | [ | ||
| Ethanol (M1) | 1.54 ± 0.07 | IC50 mg/mL | [ | ||
| Ethanol (M2) | 1.37 ± 0.04 | IC50 mg/mL | [ | ||
| Methanol (M1) | 2.69 ± 0.03 | IC50 mg/mL | [ | ||
| Methanol (M2) | 1.64 ± 0.01 | IC50 mg/mL | [ | ||
| Ethyl acetate (M1) | 3.62 ± 0.04 | IC50 mg/mL | [ | ||
| Ethyl acetate (M2) | 1.44 ± 0.08 | IC50 mg/mL | [ | ||
| Ferrous-ion chelation | Water (M1) | 113.01 ± 10.62 | IC50 mg/mL | [ | |
| Water (M2) | 74.00 ± 1.81 | IC50 mg/mL | [ | ||
| Ethanol (M1) | 5.26 ± 0.27 | IC50 mg/mL | [ | ||
| Ethanol (M2) | 10.49 ± 0.44 | IC50 mg/mL | [ | ||
| Methanol (M1) | 8.36 ± 0.29 | IC50 mg/mL | [ | ||
| Methanol (M2) | 10.07 ± 0.18 | IC50 mg/mL | [ | ||
| Ethyl acetate (M1) | 1.57 ± 0.03 | IC50 mg/mL | [ | ||
| Ethyl acetate (M2) | 5.88 ± 0.26 | IC50 mg/mL | [ |
M1—Extraction by sonication + stirring; M2—Sohxlet extraction; a mg l-ascorbic acid equivalent per 100 g of dry weight.
Anticancer activity of Asparagopsis spp.
| Species | Experimental Assay | Extract/Control | Result | Units | Ref. |
|---|---|---|---|---|---|
|
| Cytotoxicity (Daudi cells) | Dichloromethane–ethanol (1:1) | 32.52 ± 7.33 | % reduction of viable cells at 100 μg/mL after 24 h incubation | [ |
| Cytotoxicity (Jurkat cells) | 30.07 ± 7.24 | % reduction of viable cells at 100 μg/mL after 24 h incubation | [ | ||
| Cytotoxicity (HepG-2 cells) | Methanol | 567.9 | IC50 in μg/mL | [ | |
| Dichloromethane | 473.1 | IC50 in μg/mL | [ | ||
| Cisplatin (positive control) | 136.5 | IC50 in μg/mL | [ | ||
| Cytotoxicity (Caco-2 cells) | Methanol | 823.0 | IC50 in μg/mL | [ | |
| Dichloromethane | 531.6 | IC50 in μg/mL | [ | ||
| Cisplatin (positive control) | 80.11 | IC50 in μg/mL | [ | ||
| Antiproliferative activity (HepG-2 cells) | Methanol | 857.3 | IC50 in μg/mL | [ | |
| Dichloromethane | 518.9 | IC50 in μg/mL | [ | ||
| Cisplatin (positive control) | 22.63 | IC50 in μg/mL | [ | ||
| Tamoxifen (positive control) | 16.97 | IC50 in μg/mL | [ | ||
| Antiproliferative activity (Caco-2 cells) | Methanol | 508.1 | IC50 in μg/mL | [ | |
| Dichloromethane | 271.5 | IC50 in μg/mL | [ | ||
| Cisplatin (positive control) | 92.00 | IC50 in μg/mL | [ | ||
|
| Cytotoxicity (A549 cells) | Chloroform-methanol (2:1) | 98.02 ± 0.23 | IC50 in μg/mL | [ |
| Ethanol | >200 | IC50 in μg/mL | [ | ||
| Colchicine (positive control) | 2.78 ± 0.71 | IC50 in μg/mL | [ |
Antimicrobial activity of Asparagopsis extracts.
| Species | Experimental Assay | Extract/Compound | Target Species | Result | Units | Ref. |
|---|---|---|---|---|---|---|
|
| Agar-diffusion method | Dichloromethane (2 mg/disk) |
| 19.3 ± 1.3 | Inhibition zone diameter (mm) | [ |
|
| 26.9 ± 2.2 | Inhibition zone diameter (mm) | [ | |||
|
| 17.0 ± 2.2 | Inhibition zone diameter (mm) | [ | |||
|
| 14.9 ± 2.7 | Inhibition zone diameter (mm) | [ | |||
|
| 15.3 ± 1.7 | Inhibition zone diameter (mm) | [ | |||
| Solid (fresh) (2 mg/well) |
| 29.4 | Inhibition zone diameter (mm) | [ | ||
|
| 30.2 | Inhibition zone diameter (mm) | [ | |||
|
| 22.2 | Inhibition zone diameter (mm) | [ | |||
|
| 20.8 | Inhibition zone diameter (mm) | [ | |||
|
| 25.5 | Inhibition zone diameter (mm) | [ | |||
|
| 32 | Inhibition zone diameter (mm) | [ | |||
| Solid (lyophilized) (2 mg/well) |
| 38.9 | Inhibition zone diameter (mm) | [ | ||
|
| 51.1 | Inhibition zone diameter (mm) | [ | |||
|
| 35.1 | Inhibition zone diameter (mm) | [ | |||
|
| 39.9 | Inhibition zone diameter (mm) | [ | |||
|
| 27.3 | Inhibition zone diameter (mm) | [ | |||
|
| 53.2 | Inhibition zone diameter (mm) | [ | |||
| Methanol (0.3 mg/disk) |
| 11 | Inhibition zone diameter (mm) | [ | ||
| Dichloromethane (0.3 mg/disk) |
| 12 | Inhibition zone diameter (mm) | [ | ||
|
| 8 | Inhibition zone diameter (mm) | [ | |||
| Chloramphenicol |
| 30 | Inhibition zone diameter (mm) | [ | ||
| Fungal growth measurement | Dichloromethane |
| 119.8 | IC50 in μg/mL | [ | |
|
| 97.6 | IC50 in μg/mL | [ | |||
| Amphotericin B (positive control) |
| 21.6 | IC50 in μg/mL | [ | ||
| Broth microdilution | Dichloromethane—methanol (1:1) |
| 83.7 | IC50 in μg/mL | [ | |
|
| 540.6 | IC50 in μg/mL | [ | |||
|
| 374.3 | IC50 in μg/mL | [ | |||
|
| 613.8 | IC50 in μg/mL | [ | |||
|
| 528.6 | IC50 in μg/mL | [ | |||
| Agar-diffusion method (using 3 cm thallus) | Fresh thallus |
| 11.0 | Inhibition zone diameter (mm) | [ | |
|
| 9.0 | Inhibition zone diameter (mm) | [ | |||
|
| 11.0 | Inhibition zone diameter (mm) | [ | |||
|
| 12.0 | Inhibition zone diameter (mm) | [ | |||
|
| 12.0 | Inhibition zone diameter (mm) | [ | |||
| Agar-diffusion method | Methanol (500 μg/disk) |
| 10–15 | Inhibition zone diameter (mm) | [ | |
|
| 10–15 | Inhibition zone diameter (mm) | [ | |||
| Acetone |
| >15 | Inhibition zone diameter (mm) | [ | ||
| Chloroform |
| 10–15 | Inhibition zone diameter (mm) | [ | ||
| Dichloromethane—methanol (1:1) |
| 10–15 | Inhibition zone diameter (mm) | [ | ||
| Bacterial growth measurement | Dichloromethane—methanol (1:1) |
| 5.7 ± 0.1 | % growth inhibition at 1 mg/mL | [ | |
| Dichloromethane—methanol (1:1) Fraction 1 by VLC |
| 836.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 2 by VLC |
| 293.5 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 3 by VLC |
| 162.9 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 4 by VLC |
| 191.9 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 5 by VLC |
| 265.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 6 by VLC |
| 379.0 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) |
| 23.5 ± 0.6 | % growth inhibition at 1 mg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 1 by VLC |
| >1000 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 2 by VLC |
| 588.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 3 by VLC |
| 443.8 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 4 by VLC |
| 437 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 5 by VLC |
| 421.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 6 by VLC |
| 872.4 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) |
| 86.0 ± 8.3 | % growth inhibition at 1 mg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 1 by VLC |
| 414.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 2 by VLC |
| 152.7 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 3 by VLC |
| 54.4 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 4 by VLC |
| 75.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 5 by VLC |
| 83.8 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 6 by VLC |
| 244.5 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) |
| 35.1 ± 5.7 | % growth inhibition at 1 mg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 1 by VLC |
| 41.1 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 2 by VLC |
| 19.6 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 3 by VLC |
| 41.7 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 4 by VLC |
| 60.4 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 5 by VLC |
| 52.5 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 6 by VLC |
| 89.9 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) |
| 0.0 ± 4.1 | % growth inhibition at 1 mg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 1 by VLC |
| 18.9 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 2 by VLC |
| 14.5 | IC50 in μg/mL | [ | ||
| Bacterial growth measurement | Dichloromethane—methanol (1:1) Fraction 3 by VLC |
| 13.6 | IC50 in μg/mL | [ | |
| Dichloromethane—methanol (1:1) Fraction 4 by VLC |
| 20.0 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 5 by VLC |
| 11.7 | IC50 in μg/mL | [ | ||
| Dichloromethane—methanol (1:1) Fraction 6 by VLC |
| 17.3 | IC50 in μg/mL | [ | ||
| Alamar-blue assay [ | Hexane |
| >40 | IC50 in μg/mL | [ | |
| Dichloromethane |
| >40 | IC50 in μg/mL | [ | ||
| Ethanol (VLC fraction eluted with hexane—ethyl acetate (1:1)) |
| 10 | IC50 in μg/mL | [ | ||
| Ethanol (VLC fraction eluted with ethyl acetate) |
| 19 | IC50 in μg/mL | [ | ||
| Pentamidin (positive control) |
| 0.9–1 | IC50 in μg/mL | [ | ||
| Amphotericin B (positive control) |
| 0.18–0.19 | IC50 in μg/mL | [ | ||
|
| Antibacterial/antifungal activity (growth measurement) | Mahorone |
| 8 | MIC80 in μg/mL | [ |
| >32 | MIC80 in μg/mL | [ | ||||
| 16 | MIC80 in μg/mL | [ | ||||
|
| >10 | MIC80 in μg/mL | [ | |||
| 16 | MIC80 in μg/mL | [ | ||||
| >32 | MIC80 in μg/mL | [ | ||||
|
| >32 | MIC80 in μg/mL | [ | |||
|
| >32 | MIC80 in μg/mL | [ | |||
| 5-bromomahorone |
| 16 | MIC80 in μg/mL | [ | ||
| >32 | MIC80 in μg/mL | [ | ||||
| 32 | MIC80 in μg/mL | [ | ||||
|
| >10 | MIC80 in μg/mL | [ | |||
| 16 | MIC80 in μg/mL | [ | ||||
| >32 | MIC80 in μg/mL | [ | ||||
|
| >32 | MIC80 in μg/mL | [ | |||
|
| >32 | MIC80 in μg/mL | [ | |||
| Rifampicin (positive control) |
| 1 | MIC80 in μg/mL | [ | ||
| Novobiocin (positive control) | 0.3 | MIC80 in μg/mL | [ | |||
| Novobiocin (positive control) | 0.1 | MIC80 in μg/mL | [ | |||
| Ciprofloxacin (positive control) |
| 1.5 | MIC80 in μg/mL | [ | ||
| Imipenem (positive control) | 8 | MIC80 in μg/mL | [ | |||
| Penicillin (positive control) | 0.01 | MIC80 in μg/mL | [ | |||
| Alamar-blue assay [ | Hexane |
| 17 | IC50 in μg/mL | [ | |
| Dichloromethane |
| 16 | IC50 in μg/mL | [ | ||
| Ethanol (VLC fraction eluted with hexane–ethyl acetate (1:1)) |
| 14 | IC50 in μg/mL | [ | ||
| Ethanol (VLC fraction eluted with ethyl acetate) |
| 20 | IC50 in μg/mL | [ |
Antiviral activity of Asparagopsis extracts.
| Species | Experimental Assay | Extract | Target Virus | Result | Units | Ref. |
|---|---|---|---|---|---|---|
|
| Plaque infectivity reduction | Hexane (20 μg/mL) | H5N1 | 50 | % inhibition | [ |
| Hexane (40 μg/mL) | H5N1 | 57 | % inhibition | [ | ||
| Petroleum ether (20 μg/mL) | H5N1 | 73 | % inhibition | [ | ||
| Petroleum ether (40 μg/mL) | H5N1 | >99.9 | % inhibition | [ | ||
| Ethyl acetate (20 μg/mL) | H5N1 | 46 | % inhibition | [ | ||
| Ethyl acetate (40 μg/mL) | H5N1 | 55 | % inhibition | [ | ||
| Methylene chloride–ethanol (1:1) (20 μg/mL) | H5N1 | 0 | % inhibition | [ | ||
| Methylene chloride–ethanol (1:1) (40 μg/mL) | H5N1 | 15 | % inhibition | [ | ||
| Water (20 μg/mL) | H5N1 | >99.9 | % inhibition | [ | ||
| Water (40 μg/mL) | H5N1 | >99.9 | % inhibition | [ | ||
|
| Antiviral assays based on cell viability | Methanol | HSV-1 | 7.7 | EC50 in μg/mL | [ |
| Choloform–methanol (3:2) | HSV-1 | 40.9 | EC50 in μg/mL | [ | ||
| Dichloromethane | HSV-1 | 22.8 | EC50 in μg/mL | [ | ||
| Water | HSV-1 | <2.5 | EC50 in μg/mL | [ |
Enzyme inhibition activity of Asparagopsis spp.
| Species | Target Enzyme | Experimental Assay | Extract/Compound | Result | Units | Ref. |
|---|---|---|---|---|---|---|
|
| Acetylcholinesterase | Ellman method [ | Methanol | 58.4 ± 1.0 | % inhibition at 10 mg/mL | [ |
| Galantamine (positive control) | 90.3 ± 0.6 | % inhibition at 1 mg/mL | [ | |||
| Butyrylcholinesterase | Ellman method [ | Methanol | 66.8 ± 1.3 | % inhibition at 10 mg/mL | [ | |
| Galantamine (positive control) | 80.3 ± 0.1 | % inhibition at 1 mg/mL | [ | |||
| Tyrosinase | Method reported by Nerya et al. [ | Methanol | 81.4 ± 5.2 | % inhibition at 10 mg/mL | [ | |
| Arbutin (positive control) | 78.0 ± 0.1 | % inhibition at 1 mg/mL | [ | |||
| Phospholipase A2 | Colorimetric assay [ | Dichloromethane-methanol (1:1) | 100 | % inhibition at 1 μg/mL | [ | |
| Elastase | Colorimetric assay [ | Dichloromethane-methanol (1:1) | 55 | % inhibition at 10 μg/mL | [ | |
|
| Acetylcholinesterase | Ellman method [ | Dichloromethane | 116.50 ± 10.94 | IC50 in μg/mL | [ |
| Chloroform-methanol (2:1) | 8.92 ± 0.43 | IC50 in μg/mL | [ | |||
| Ethanol | 46.33 ± 6.02 | IC50 in μg/mL | [ | |||
| Donepezil (positive control) | 0.01 ± 0.00 | IC50 in μg/mL | [ | |||
| Galantamine (positive control) | 0.43 ± 0.09 | IC50 in μg/mL | [ | |||
| Butyrylcholinesterase | Ellman method [ | Chloroform-methanol (2:1) | 13.96 ± 0.32 | IC50 in μg/mL | [ | |
| Ethanol | 28.10 ± 0.93 | IC50 in μg/mL | [ | |||
| Donepezil (positive control) | 55.62 ± 3.47 | IC50 in μg/mL | [ | |||
| Galantamine (positive control) | >150 | IC50 in μg/mL | [ |
The results of these studies should encourage further research on this topic.
General composition of Asparagopsis species.
| Constituents |
|
|
|---|---|---|
| Water | 90.8–91.2 g/100 g fw [ | 92.6 g/100 g fw [ |
| Polysaccharides | Starch 1.26 g/100 g dw [ | Starch 8.03 ± 0.38 g/100 g dw [ |
|
Other 72.0 g/100 g dw [ |
Other 32.47 ± 1.04 g/100 g dw [ | |
| Protein | 10.9–14.0 g/100 g dw [ | 17.55 ± 0.11 g/100 g dw [ |
| Lipids | 2.51 ± 0.26 g/100 g dw [ | 6.62 ± 0.54 g/100 g dw [ |
| Ashes | 13.36 ± 0.68 g/100 g dw [ | 23.76 ± 0.48 g/100 g dw [ |
fw—fresh-weight basis; dw—dry-weight basis.
Figure 1Chemical structures of sterols identified in Asparagospis species.
Figure 2Chemical structures of two 2,3-dibromocyclopentone derivatives identified in Asparagospis taxiformis.
Figure 3Chemical structure of mycosporine-like amino acids accumulated in A. armata.